375 related articles for article (PubMed ID: 32098295)
1. Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines.
Uysal-Onganer P; MacLatchy A; Mahmoud R; Kraev I; Thompson PR; Inal JM; Lange S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098295
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
3. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
4. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
[TBL] [Abstract][Full Text] [Related]
5. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
6. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
[TBL] [Abstract][Full Text] [Related]
7. Post-Translational Deimination of Immunological and Metabolic Protein Markers in Plasma and Extracellular Vesicles of Naked Mole-Rat (
Pamenter ME; Uysal-Onganer P; Huynh KW; Kraev I; Lange S
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671738
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Mould R; Nunn AV; Guy GW; Kraev I; Chatterton NP; Thomas EL; Inal JM; Bell JD; Lange S
Transl Oncol; 2019 Mar; 12(3):513-522. PubMed ID: 30597288
[TBL] [Abstract][Full Text] [Related]
9. Deimination Protein Profiles in
Criscitiello MF; Kraev I; Petersen LH; Lange S
Front Immunol; 2020; 11():651. PubMed ID: 32411128
[TBL] [Abstract][Full Text] [Related]
10. Acute Hypoxia Alters Extracellular Vesicle Signatures and the Brain Citrullinome of Naked Mole-Rats (
D'Alessio S; Cheng H; Eaton L; Kraev I; Pamenter ME; Lange S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563075
[TBL] [Abstract][Full Text] [Related]
11. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
12. Post-translational protein deimination signatures in sea lamprey (Petromyzon marinus) plasma and plasma-extracellular vesicles.
Rast JP; D'Alessio S; Kraev I; Lange S
Dev Comp Immunol; 2021 Dec; 125():104225. PubMed ID: 34358577
[TBL] [Abstract][Full Text] [Related]
13. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles and post-translational protein deimination signatures in haemolymph of the American lobster (Homarus americanus).
Bowden TJ; Kraev I; Lange S
Fish Shellfish Immunol; 2020 Nov; 106():79-102. PubMed ID: 32731012
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
17. The Proteome and Citrullinome of
Magnadóttir B; Kraev I; Dodds AW; Lange S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467210
[TBL] [Abstract][Full Text] [Related]
18. Post-Translational Protein Deimination Signatures in Serum and Serum-Extracellular Vesicles of
Criscitiello MF; Kraev I; Lange S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325910
[TBL] [Abstract][Full Text] [Related]
19. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
20. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
